Embark Delta Inc. Completes First Shipment to Province of Ontario
Toronto, Ontario–(Newsfile Corp. – April 12, 2021) – Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. (“Embark” or the “Company”) is pleased to announce the Company has successfully completed its first product shipment to the Ontario Cannabis Store (“OCS”) with The Hank Co. Bubble Hash. The OCS is the wholesaler and online retailer for recreational cannabis in Ontario.
“As Canada’s largest market for adult-use cannabis products, the successful fulfillment to the OCS is a significant accomplishment for Embark,” said Dr. Luc C. Duchesne, CEO. “Embark looks forward to continuing the rollout of our other concentrate products, specifically the Hazel Hash Stick, to Ontario consumers in the coming week.”
Figure 1: Embark’s solventless concentrate brand, The Hank Co.
To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/7351/80104_fe7ff94804d96bf8_001full.jpg
The Hank Co. is part of Embark’s line of 2.0 solventless concentrate brands. Embark is thrilled with the launch of Hank bubble hash in Ontario and looks forward to the expansion of other concentrate products including the upcoming shipment of the Hazel hash sticks in addition to future concentrate products such as pressed hash, rosin and drysift.
About Embark Health Inc.
Embark Health Inc. is a leader in solventless cannabis extraction, with a focus on the formulation and production of advanced 2.0 products for the B2B, medical and adult-use markets. Embark continues to be at the forefront of production of concentrate products including bubble hash, traditional pressed hash, rosin, and dry sift. With the acquisition of Embark Nano Inc. (“Nano”, formerly, Axiomm Technologies Ltd.) in Q3 of 2020, Embark is preparing to launch the next generation of Cannabis 2.0 products. The acquired portfolio of products and formulations support the mass production and distribution of advanced 2.0 products including cannabis-infused beverages, topicals, edibles and water-soluble powders. For more information, please visit www.embarknano.com.
It is Embark’s mandate to pursue best-in-class production processes resulting in premium quality commercial and consumer extraction products. Embark Health Inc. is dedicated to unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. For more information, please visit www.embarkhealthinc.com.
Investor Relations Contact:
IR@embarkhealthinc.com
FORWARD LOOKING STATEMENTS
This news release contains “forward-looking information” within the meaning of applicable securities laws including statements regarding the ability to leverage its existing Cannabis 2.0 products for the Canadian market, access to future markets, Embark’s ability to increase production and offer new products and services following receipt of applicable licences, the continued business-to-business activities of Embark, and the effects of the aforementioned activities on the operational and financial condition of Embark. Although Embark believes in light of the estimates by management, current conditions and expected future developments and other factors, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them. Accordingly, Embark can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in economic conditions or financial markets; regulatory delays; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. The statements in this press release are made as of the date of this release. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company.
NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80104
